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Abstract
In this chapter, we describe the complex relationship between angiogenesis and skeleto-
genesis. While much is known about the interactions of these two dynamic systems for 
bones that ossify via a cartilage template, comparatively little is known about directly 
ossifying bones. Most of the bones of the head develop from osteogenic condensations 
and undergo intramembranous (direct) ossification during development. Our under-
standing of the relationship between osteogenic cell condensations (in particular) and 
angiogenesis is currently inadequate and prevents a comprehensive understanding of 
vertebrate head development. This chapter highlights our understanding of both direct 
and indirectly ossifying bones shedding light on where there are important gaps in our 
understanding.
Keywords: avascular, skeletogenic condensation, osteoblasts, chondrocytes, cell culture, 
VEGF, HIF
1. Introduction
The coordinated development of tissues is critical for proper development. Bone is a highly 
vascularized tissue that also houses the hematopoetic cell niche, which provides a lifelong 
supply of blood cells (in humans and most other vertebrates). In this chapter, we will explore 
the role angiogenesis plays during the development of bones. Bones that ossify endochon-
drally (from cartilage) versus bones that ossify intramembranously (without cartilage) have 
different relationships with vasculature and hence with the process of angiogenesis. These 
bones start development by forming a skeletogenic condensation, however, the molecu-
lar  signals within these condensations differ [1]. We begin with a discussion of bones that 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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develop from a cartilage precursor (endochondral ossification) since more is known about 
this process than about directly ossifying bones (intramembranous ossification). We also dis-
cuss data from cell culture and bone grafts that shed light on the cross talk between these two 
dynamic processes, angiogenesis and skeletogenesis. Some pathological implications are also 
included.
2. Bones that ossify via endochondral ossification
2.1. Angiogenesis during formation of the cartilage template
Endochondrally ossifying bones are bones that form via a cartilage template. The process of 
endochondral ossification begins with stem cells originating from the mesenchyme in the 
future area of bone development. These stem cells aggregate to form a chondrogenic con-
densation. Once this cell aggregation reaches a critical size, cells begin to differentiate into 
chondrocytes (chondroblasts) that will then secrete extracellular matrix (ECM), collagen 
type II. This matrix matures into the cartilage template that will eventually ossify (e.g., long 
bones). Cartilage itself is avascular when first deposited, however, differentiated chondro-
cytes secrete anti-angiogenic factors (inhibitors) to maintain the avascular nature of the car-
tilage. These early chondrocytes are typically referred to as pre-hypertrophic chondrocytes. 
As these chondrocytes mature, they gradually become hypertrophic and begin to secrete a 
number of pro-angiogenic factors. Vascular endothelial-derived growth factor (VEGF), a pro-
tein which is important for angiogenesis and the subsequent ossification of the cartilage, is a 
key angiogenic factor during bone development. Hypoxia-inducible factor is one of the key 
upstream regulators of VEGF, and changes in the level of HIF can alter the level of VEGF thus 
dramatically changing bone mass (discussed later).
During the maturation of hypertrophic chondrocytes, these cells release VEGF into the extra-
cellular matrix and into the area surrounding the perichondrium layer of the cartilage. The 
hypertrophic chondrocytes also secrete fibroblast growth factor (FGF), bone morphogenetic 
protein (BMP) and connective tissue growth factor (CTGF) [2, 3]. With the arrival of these fac-
tors to the site of bone formation, angiogenesis in the bone can now occur. There is a complex 
cross talk between bone-forming cells (osteoblasts), the angiogenic factors present, and the 
invading vasculature. These growth factors, in particular VEGF, recruit osteo/chondro-clasts, 
osteoprogenitors and other bone precursors to the area in order to initiate the primary ossifi-
cation center, the first site of bone formation within the cartilage template [2, 4].
Osteoclasts are bone matrix resorbing cells, and once recruited, they secrete multiple factors 
that contribute to the initiation of vascularization, including the release of more VEGF and 
FGFs [2, 5]. Among these factors are matrix metalloproteinases (MMPs) and hypoxia-induc-
ible factors (HIFs) which, along with VEGF, are other key proteins important in the devel-
opment of vasculature in bone. The MMPs break down the ECM and release matrix-bound 
VEGF that allows for the resorption of cartilage so that osteoblasts can infiltrate and deposit 
bone. MMPs, primarily MMP9 and MMP13, also function to recruit osteoclasts and osteopro-
genitors, further aiding in the subsequent deposition of bone [2, 4]. The matrix-bound VEGF 
that is released is a key player in the formation of bone vasculature. HIFs regulate VEGF 
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expression in bone, which has an effect on angiogenesis [2]. Thus VEGF, MMPs and HIFs play 
a central role in angiogenesis during endochondral ossification.
2.2. Vascular invasion of the cartilage
Vascular invasion of the cartilage template is the first major step in angiogenesis in the develop-
ing bone. The vasculature from the perichondrium penetrates the previously avascular cartilage 
and begins to invade the rest of the cartilage. Vascular invasion is coupled to a number of events 
in the cartilage, the degradation of the extracellular matrix by MMPs, which releases matrix-
bound VEGF and favors the invasion of the cartilage, as well as apoptosis of the hypertrophic 
chondrocytes which were responsible for secreting many of the growth factors that resulted in 
the invasion [2, 4, 6]. As vasculature penetrates the cartilage and the hypertrophic chondrocytes 
undergo apoptosis, they are promptly replaced by osteoblasts in the resulting bone cavity (i.e., 
by the osteoblasts previously recruited by factors such as VEGF). These osteoblasts then secrete 
collagen type I to initiate ossification to form the bone matrix in the primary ossification center. 
The same growth factors in and around the growth plate of the bone will allow the vasculature 
to continue its invasion of the bone to the secondary ossification centers located at either ends of 
the long bone, in the same way that the primary ossification centers were formed [2].
Angiogenesis during endochondral ossification is heavily dependent on the cellular compo-
nents of the skeleton, namely osteoblasts and chondrocytes. Without these cells, the valuable 
pro-angiogenic factors would not be properly secreted and will not be able to induce vascular 
invasion. However, the reverse is also true. In order for bone to continue to form properly, effi-
cient and effective vascular invasion is required. The vasculature that invades cartilage likely 
also carries required factors for bone growth; the vascular epithelium is thought to carry osteo-
progenitors, more VEGF, FGFs and other factors which assist with the resorption of the sur-
rounding cartilage and the ossification of bone [6]. Without vasculature invading the cartilage, 
bone formation is impaired. A study on mouse long bones showed that expression of SOX9 can 
block the expression of VEGFA, which results in impaired vascular invasion, and as a result, the 
bones do not ossify [7]. (SOX9 is a key marker of chondrogenic condensations [1].) VEGF also 
plays a role in the ongoing maintenance of bone vasculature endogenous VEGF was shown to 
enhance vascularization of bone and subsequently allows more rapid healing of injured bones, 
indicating the role of vascularization in the formation and turnover of endochondral bone [6].
Along with VEGF, another key factor in the invasion of vasculature into bone is hypoxia. The 
lack of oxygen will result in the release of hypoxia-inducible factors (HIFs) which regulate the 
production of the extracellular matrix and VEGF expression. The matrix binds VEGF triggering 
vascular invasion. The HIFs expressed by osteoblasts support both the proper vascularization 
of bone as well as the proper functioning of osteoblasts. Increased expression of HIFs results in 
more vascularization and thicker bones, whereas deletion of HIFs (and the resulting reduced 
expression of VEGF) results in less vascularization and thinner bones [2]. Thus, VEGFs and 
HIFs are two major factors that couple angiogenesis to endochondral bone formation [2, 6].
Thus in summary, endochondral ossification is dependent on the interaction between pro-
angiogenic factors acting on bone-forming cells (Figure 1), and endochondral ossification is 
impaired in the absence of these factors.
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Figure 1. Schematic showing the complex cross talk between angiogenesis and skeletogenesis. Mesenchymal cells 
aggregate in an avascular (hypoxic) zone to form skeletogenic condensations. Differences in the molecular characteristics 
of these cells determine the fate of the condensation. Cells within this condensation produce VEGF and other pro-
angiogenic factors, and this induces angiogenesis. Left side: Cells within the chondrogenic condensation continue to 
produce these angiogenic factors, and ultimately, the condensation differentiates into a cartilage template, which is still 
avascular. Following angiogenesis surrounding this template, blood vessels invade the cartilage perichondrium layer, 
and this triggers osteoblast differentiation, cartilage matrix degradation, bone matrix production and the further release 
of more pro-angiogenic factors. Ossification begins in the diaphysis (shaft) of long bones and spreads to the epiphyses 
(ends of the bone). Right side: As cells within the skeletogenic condensation differentiate, they continue to produce 
angiogenic factors. These factors induce angiogenesis and subsequent blood vessel invasion into the outer edges of the 
condensation. As more cells within the condensation differentiate, the wave of bone matrix deposition and blood vessel 
invasion spreads outwards.
Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy50
3. Bones that ossify via intramembranous ossification
3.1. Directly ossifying bones
Intramembranously ossifying bones form without a cartilage template. Motile mesenchymal 
cells fated to differentiate into osteoblasts aggregate to from skeletogenic condensations at the 
site of the future bone. As these osteogenic aggregations enlarge and reach a critical size, the 
central cells begin to differentiate into osteoblasts, lose their mobility and deposit bone matrix. 
This process results in osteoblasts becoming embedded or trapped in bone matrix, forcing 
them to differentiate into osteocytes [8]. The majority of the craniofacial skeleton forms via 
intramembranous ossification [9]. A common example is the skull vault (the calvariae). Less 
common examples are the scleral ossicles (in reptiles), parts of the clavicles and scapula (in 
mammals), the cleithra and opercula (in fish) and sesamoid bones (e.g., the patella in humans) 
[9]. Although vascularization has been extensively studied in endochondral ossification as 
discussed above, comparatively little research has been conducted to understand the relation-
ship between angiogenesis and intramembranous ossification.
3.2. Angiogenesis during formation of the initial phase of directly ossifying bones
The most studied intramembranous bones are the calvariae (or skull vault). Cells in the osteo-
genic condensations proliferate resulting in growth of the condensations until a critical size 
is reached. Ossification begins at the center of the condensation and expanding outwards 
toward the apex of the head [10]. Once this has occurred, cells at the osteogenic front prolif-
erate, and the bones grow toward one another [11]. Areas that ossified first form a trabecu-
lar bone structure that later becomes woven bone [10]. Interestingly, the frontal and parietal 
bones in humans each develop two condensations, each with their own ossification centers; 
these centers then fuse as ossification progresses [12].
There is a significant difference in the gene expression patterns in prechondrogenic and 
preosteogenic condensations [1]. Avascularity within condensations may be necessary for 
the formation of the condensations themselves and/or to provide positional cues [10, 13]. 
Indeed, in scleral ossicles, an avascular zone develops surrounding the condensation [14, 15]. 
Manipulating the size of this avascular zone has a direct effect on subsequent bone develop-
ment [15]. Although not much is known about the process of vascularization during intra-
membranous ossification, it is thought that similar to endochondral bones, hypoxic conditions 
are important to induce angiogenesis. Avascular zones likely surround all preosteogenic con-
densations in mammals and avians, however, the mechanism by which these zones are estab-
lished is not known [10]. Percival and colleagues [10] postulate that this avascularity may be 
important for condensation growth, and subsequent intramembranous ossification (as in the 
case for prechondrogenic condensations of endochondrally ossifying bones, Figure 1).
A single study describes in detail, the association of angiogenesis and intramembranous 
bones [16]. This study of the development of the chick frontal bone showed that small capil-
laries invade the thin avascular layer of loose mesenchymal cells of the condensation prior to 
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invading the condensation at/near the site of initial ossification [16]. This association between 
vascular invasion and ossification continues and cascades as the bone expands in all direc-
tions. As the bone mineralizes in the wake of this vascular invasion front, the internal and 
external vasculature is remodeled.
Based on studies of endochondral ossification and distraction osteogenesis, Percival and col-
leagues [10] recently developed a model of angiogenesis during intramembranous ossification. 
They propose that prior to the onset of mineralization, small capillaries begin to invade the sur-
rounding avascular loose mesenchymal tissue due to the presence of pro-angiogenic factors. At 
around the time of mineralization onset, these capillaries invade the osteogenic condensations 
and branch outwards from the ossification center (Figure 1). These capillaries branch toward 
regions of pro-angiogenic factor expression and thus support the proliferating mesenchymal 
cells of the condensation. Mineralization thus first occurs at sites closest to the capillaries and 
then at sites progressively further away. Once the osteogenic condensation stops expanding, 
the capillaries along with the mineralization front continue to moves toward the presumptive 
sutures (i.e., the edges of the future bone), thus allowing continued calvarial growth.
Interestingly, while osteoblasts in endochondrally ossifying bones express both HIF1α and 
HIF2α, only HIF2α is detected in the osteoblasts of directly ossifying bones (i.e., those that 
undergo intramembranous ossification) [17]. This altered expression pattern of the HIFα sub-
units could suggest that alternative regulatory pathways trigger angiogenesis in these dis-
tinct types of ossification [17]. Percival and Richtsmeier [10] provide a comprehensive list of 
hypotheses relating to intramembranous osteogenesis and angiogenesis that require testing. 
The cross talk between these two dynamic processes is summarized in Figure 1.
4. Insights from cell culture and bone graft studies
VEGF is a chemoattractant for primary osteoblasts and mesenchymal progenitor cells [18] 
and can directly promote differentiation of primary human osteoblasts in culture in a dose-
dependent manner [19]. Osteoblasts and mesenchymal stem cells are the two cell types most 
often used in bone tissue engineering. Interestingly, the type of cell used can influence the 
mode of ossification that occurs and the organization of blood vessels [20]. Implantation of 
osteoblasts leads to the formation of fibrous tissue and disorganized blood vessels. The osteo-
blasts become trapped in the secreted bone matrix (i.e., intramembranous ossification occurs). 
In contrast, implantation of stem cells leads to the formation of cartilaginous tissue (i.e., endo-
chondral ossification) and well-organized blood vessels.
Basic fibroblast growth factor (bFGF) is another important pro-angiogenic factor. When 
bone mesenchymal stem cells were transfected with bFGF and then implanted into rats 
with calvarial defects, an increase in vascularization and osteogenesis was observed [21]. 
Similarly, the addition of sonic hedgehog (Shh) in engineered bone grafts in vitro also pro-
motes v ascularization of the grafts [22]. Shh is expressed during fracture healing and 
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 neovascularization after trauma and has been used in vitro to promote the organization of 
blood vessels in artificial tissue grafts similarly to VEGF [22, 23]. Furthermore, when these 
grafts were implanted subcutaneously in mice, there was increased bone formation of both 
directly and indirectly ossifying bone types [22]. For large defects, supplementing the graft 
with platelet-rich plasma results in increased bone formation [24].
5. Pathological implications
The role of growth factors like VEGF, FGF, CTGFs and others in both bone growth and angio-
genesis has been demonstrated in a number of recent studies investigating the growth and 
healing of bones. For example, FGF9+/- mice exhibit a reduction in the healing of bones accom-
panied by a lack of VEGF expression in the area of injury, suggesting that FGF9 is required 
for angiogenesis and for healing long bones [25]. Hypomorphic VEGF120/120 mice have reduced 
mineralization of the calvarial bones and consequently reduced bone thickness. This has been 
attributed to a reduction and delay in vascular invasion [26]. Additionally, conditional deletion 
of VEGFA in mice cranial neural crest cells causes cleft palate with reduced ossification of the 
mandibular bone due to reduced endothelial cell proliferation and decreased angiogenesis [27]. 
Mice with a VEGF-deficient osteoblastic lineage exhibit age-dependent loss of bone mass and 
increased bone marrow fat, similar to the changes associated with osteoporosis in humans [28].
6. Conclusions and summary
VEGF mediates angiogenesis, chondrocyte differentiation, osteoblast differentiation and 
osteoclast recruitment [29], and thus, its role during osteogenesis is complex ([10], Figure 1). 
Yang et al. [30] provide a useful tabulation of the effects of VEGF on intramembranous and 
endochondral ossification. Importantly, this chapter highlights that the relationship between 
angiogenesis and intramembranous ossification is not well understood. For example, only 
one study describes the detailed relationship between these two dynamic systems [16], and 
a very recent study provides a model of this process [10]. This model should be examined in 
several directly ossifying bones in the skeleton in order to confirm whether all directly ossi-
fying bones follow the model or whether subtle differences exist depending perhaps on the 
location of the bone or the origin of the bone cells. This lack of a fundamental understanding 
about the developmental interactions between angiogenesis and skeletogenic condensations 
(particularly with respect to directly ossifying bones) contributes to our inadequate under-
standing of skull formation [10].
It should be noted that bones that ossify from the perichondrium of a cartilage template can 
be considered endochondral or intramembranous (since the perichondrium is a membrane of 
the cartilage). An example is Meckel’s cartilage. The relationship between angiogenesis and 
bones that develop via the perichondrium has not been studied.
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